0.56
-0.0117(-2.03%)
Currency In USD
| Previous Close | 0.57 |
| Open | 0.58 |
| Day High | 0.59 |
| Day Low | 0.56 |
| 52-Week High | 2.95 |
| 52-Week Low | 0.5 |
| Volume | 232,428 |
| Average Volume | 516,795 |
| Market Cap | 10.3M |
| PE | -0.19 |
| EPS | -2.91 |
| Moving Average 50 Days | 0.64 |
| Moving Average 200 Days | 0.8 |
| Change | -0.01 |
If you invested $1000 in Lifeward Ltd. (LFWD) 10 years ago, it would be worth $0.35 as of February 05, 2026 at a share price of $0.563. Whereas If you bought $1000 worth of Lifeward Ltd. (LFWD) shares 5 years ago, it would be worth $24.99 as of February 05, 2026 at a share price of $0.563.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lifeward Enters Transformative Strategic Investment and Partnership Agreement with Oramed to Create a Diversified Biomedical Innovation Company
GlobeNewswire Inc.
Jan 13, 2026 1:00 PM GMT
Positions Lifeward as a MedTech platform with a clear path to cashflow positive and long-term Biotech upside potential Up to $47 million strategic investment from Oramed and another investor is intended to provide Lifeward cash runway to profitabilit
Lifeward Appoints Bob Marshall as Chairman of the Board
GlobeNewswire Inc.
Dec 19, 2025 9:05 PM GMT
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical li
Lifeward Expands International Distribution of its ReWalk® Personal Robotic Exoskeleton into Mexico, Thailand, and the United Arab Emirates
GlobeNewswire Inc.
Dec 17, 2025 1:00 PM GMT
Distribution agreement with Singapore-based Verita Neuro will provide patients the ReWalk Personal Exoskeleton as part of its multi-layered treatment modalities New delivery model for ReWalk will integrate in-patient training and rehabilitation to su